Frederico R. Maia
Campinas, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
PD-L1 and MCL-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma.
Journal: Molecular and cellular endocrinology
Published: January 25, 2023
Extremely aggressive course in a poorly differentiated thyroid carcinoma presenting a double mutation of the TERT promoter.
Journal: The American journal of the medical sciences
Published: September 04, 2022
Influence of thyroid hormone in the expression of the marker pro-apoptosis BID, in spite of the predominance of anti-apoptosis activation in intratiroidal lymphocytic infiltration in Hashimoto's thyroiditis.
Journal: Molecular and cellular endocrinology
Published: June 12, 2021
Usefulness of pre-thyroidectomy neutrophil-lymphocyte, platelet-lymphocyte, and monocyte-lymphocyte ratios for discriminating lymph node and distant metastases in differentiated thyroid cancer.
Journal: Clinics (Sao Paulo, Brazil)
Published: April 17, 2021
Value of Apoptotic, Antiapoptotic, and Cell Proliferation Markers in the Treatment of Graves' Disease.
Journal: International journal of endocrinology
Published: October 16, 2017
Expression of Mcl-1 and Ki-67 in Papillary Thyroid Carcinomas.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: April 29, 2016
Thyroid imaging reporting and data system score combined with Bethesda system for malignancy risk stratification in thyroid nodules with indeterminate results on cytology.
Journal: Clinical endocrinology
Published: March 20, 2014
Thyroid nodule management: clinical, ultrasound and cytopathological parameters for predicting malignancy.
Journal: Clinics (Sao Paulo, Brazil)
Published: December 20, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026